Xiangmin Tong

ORCID: 0000-0001-5153-3753
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Metabolomics and Mass Spectrometry Studies
  • Immune Cell Function and Interaction
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C virus research
  • HVDC Systems and Fault Protection
  • Chronic Myeloid Leukemia Treatments
  • Cancer-related gene regulation
  • Clusterin in disease pathology
  • Cytomegalovirus and herpesvirus research
  • Autoimmune and Inflammatory Disorders Research
  • Microtubule and mitosis dynamics
  • Mass Spectrometry Techniques and Applications
  • Bone and Joint Diseases
  • Lymphoma Diagnosis and Treatment
  • Cancer-related Molecular Pathways
  • Graphene and Nanomaterials Applications
  • Nanoparticle-Based Drug Delivery
  • Clinical Laboratory Practices and Quality Control
  • Cancer, Lipids, and Metabolism
  • HER2/EGFR in Cancer Research
  • Ferroptosis and cancer prognosis
  • Hematological disorders and diagnostics
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Hangzhou First People's Hospital
2023-2024

Zhejiang Provincial People's Hospital
2017-2024

Westlake University
2024

Hangzhou Medical College
2022-2024

Lishui Central Hospital
2017-2022

Lishui University
2022

Zhejiang University
2012-2022

Wenzhou Medical University
2022

Hangzhou Xixi hospital
2017

First Affiliated Hospital Zhejiang University
2011

The GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) AFP-L3 (included in score but not score). current study sought compare diagnostic performance each detect HCC among patients infected with hepatitis C virus (HCV).A multicenter case-control was undertaken which blood samples were collected from HCVinfected without...

10.3389/fonc.2022.1018396 article EN cc-by Frontiers in Oncology 2022-09-30

Abstract Background Pancreatic cancer (PC) is one of the most malignant cancers with highly aggressiveness and poor prognosis. N6-methyladenosine (m6A) have been indicated to be involved in PC development. Glucan Branching Enzyme 1 (GBE1) mainly cell glycogen metabolism. However, function GBE1 Whether occurs m6A modification progression remains illustrated. Methods The clinical prognosis was analyzed through online platform. expression obtained from platform then verified normal lines....

10.1186/s11658-024-00611-8 article EN cc-by Cellular & Molecular Biology Letters 2024-07-03

BACKGROUND: NIMA-related kinase 2 (NEK2), a serine/threonine kinase, is located in the centrosome and member of cell cycle regulation related protein (CCRK) family. Aberrant expression NEK2 linked with carcinogenesis progression various tumors. OBJECTIVE: To investigate level its relationship clinicopathological factors hepatocellular carcinoma (HCC). METHODS: Immunohistochemistry was used to measure 310 patients' specimen tissues 197 adjacent normal liver HCC cases, subsequent prognostic...

10.3233/cbm-170586 article EN Cancer Biomarkers 2017-07-19

With the improvement of many fields such as sequencing technology, materials science and mass spectroscopy, traditional laboratory technologies applied to early detection cancer using tumor biomarkers have improved novel emerge constantly, which are summarized in this mini-review..

10.1039/c7ay00926g article EN Analytical Methods 2017-01-01

Wei OUYANG, Ming-Cheng GUAN, Si-Yu LIU, Xin-Fei XU, Li-Yang SUN, Ming-Da WANG, Feng SHEN, Xiang-Min TONG, Hong ZHU, Tian YANG*. Ann Hepatobiliary Pancreat Surg 2022;26:S306. https://doi.org/10.14701/ahbps.2022S1.EP-24

10.14701/ahbps.2022s1.ep-24 article TL Annals of Hepato-Biliary-Pancreatic Surgery 2022-04-30
Coming Soon ...